Our Team

/Our Team
Our Team 2018-11-21T15:02:35+00:00

Meet Our Team

Nicolai Braun

MSc, MA.
Berlin, Germany

Strategic Market Access

Andrea Mudd

MSc
Rotterdam, The Netherlands

Modeling & Meta-Analysis

Angelique van der Zwalm

Rotterdam, The Netherlands

Operations

Kaspar Nieland

MSc
Rotterdam, The Netherlands

Modeling & Meta-Analysis

Kirsten van Nimwegen

PhD
Rotterdam, The Netherlands

Modeling & Meta-Analysis

Lisette Nientker

MSc
Rotterdam, The Netherlands

Strategic Market Access

Loes van Erp

MSc
Rotterdam, The Netherlands

Operations

Cathelijne Alleman

MSc
Rotterdam, The Netherlands

Strategic Market Access

Corine Bogaards

Rotterdam, The Netherlands

Operations

Min Tan

PhD, MPhil
York, United Kingdom

Real-World Evidence & Data Analytics

Mark Baljeu

MSc
Rotterdam, The Netherlands

Operations

Cécile van Steen

MSc
Rotterdam, The Netherlands

Strategic Market Access

Janita Balradj

MSc
Rotterdam, The Netherlands

Strategic Market Access

Jelle Spoorendonk

MSc
Rotterdam, The Netherlands

Strategic Market Access

Joris Kleintjens

MSc
Rotterdam, The Netherlands

Modeling & Meta-Analysis

Laura ten Cate

BSc
Rotterdam, The Netherlands

Operations

Rosemary Jose

PhD
Rotterdam, The Netherlands

Strategic Market Access

Marjanne Piena

MSc
Rotterdam, The Netherlands

Modeling & Meta-Analysis

Lelita Nandkoemarsing

LL. M.
Rotterdam, The Netherlands

Operations

Marielle Tergau

MSc
Rotterdam, The Netherlands

Operations

Marja Hensen

MSc
Rotterdam, The Netherlands

Strategic Market Access

Marvin Rid

BSc
Rotterdam, The Netherlands

Operations

Siobhan Spoelman

MA
Rotterdam, The Netherlands

Operations

Susan Tempelaar

MSc
Rotterdam, The Netherlands

Modeling & Meta-Analysis

Sven Klijn

MSc
Rotterdam, The Netherlands

Modeling & Meta-Analysis

Tessa Meershoek

Rotterdam, The Netherlands

Operations

Anuj Shah

BPharm
Bethesda, United States

Real-World Evidence & Data Analytics

Beth Lesher

PharmD, BCPS
Bethesda, United States

Strategic Market Access

Candice Subero

BFA
Bethesda, United States

Operations

Caroline Seo

BA
Bethesda, United States

Patient-Reported Outcomes

Catherine Mirvis

BA
Bethesda, United States

Strategic Market Access

Charlie Iaconangelo

PhD, MS
Bethesda, United States

Patient-Reported Outcomes

Chris Moreland

BS
Bethesda, United States

Operations

Daniel Nicoloso

BS
Bethesda, United States

Modeling & Meta-Analysis

Daniel Serrano

PhD, MA
Bethesda, United States

Patient-Reported Outcomes

Della Varghese

PharmD, MS, PhD
Bethesda, United States

Real-World Evidence & Data Analytics

Eleanor Lucas

BA
Bethesda, United States

Strategic Market Access

Erin Hart

BS
Bethesda, United States

Strategic Market Access

Frieda Du

MS
Shanghai, China

Asia Pacific

Ibrahim Diakite

PhD
Bethesda, United States

Modeling & Meta-Analysis

James Marcus

PhD
Bethesda, United States

Patient-Reported Outcomes

Kathryn Lasch

PhD, MA, MSSW
Boston, United States

Patient-Reported Outcomes

Mark Bernauer

BPharm, RPh
Indianapolis, IN

Strategic Market Access

Masoom Priyadarshini

MPharm, MS
Bethesda, United States

Modeling & Meta-Analysis

Namita Joshi

PhD, MS (Pharmacy Administration), BPharmacy
Bethesda, United States

Real-World Evidence & Data Analytics; Patient-Reported Outcomes

Omer Zaidi

MPH
Boston, United States

Strategic Market Access

Patricia Benton

MBA, CPA
Bethesda, United States

Operations

Robia Zafar

BS
Bethesda, United States

Operations

Ruchit Shah

BPharm, PhD
Bethesda, United States

Real-World Evidence & Data Analytics

Sarah Ronnebaum

PhD
Bethesda, United States

Strategic Market Access

Sarah Tabish

MS
Bethesda, United States

Operations

Sharon Bickford

MPA
Bethesda, United States

Operations

Sonya Snedecor

PhD
Bethesda, United States

Modeling & Meta-Analysis

Stephan Martin

BS
Bethesda, United States

Strategic Market Accesss

Stephen Buschman

BS
Bethesda, United States

Operations

Thelma Muronzi

MS, Security+
Bethesda, United States

Operations

Barbara Potrata

Rotterdam, The Netherlands

Patient-Reported Outcomes

Lex Tergau

Msc
Rotterdam, The Netherlands

Operations

Esra Cakar

MSc
Rotterdam, The Netherlands

Modeling & Meta-Analysis

Daan Mathijssen

MSc
Rotterdam, The Netherlands

Modeling & Meta-Analysis

Annemarie van Gogh

LLM
Rotterdam, The Netherlands

Operations

Claire Zhang

BA
Bethesda, United States

Modeling & Meta-Analysis

Erik Allen

Bethesda, United States

Operations

James Eaton

MSc
York, United Kingdom

Strategic Market Access

Allysen Kaminski

BA
Bethesda, United States

Strategic Market Access

Kelly McCarrier

PhD, MPH
Bethesda, United States

Patient-Reported Outcomes

Xiacong Li

PhD, MHA, BMed
Bethesda, United States

Real-World Evidence & Data Analytics

Katie Farrey

BS
Bethesda, United States

Operations

Georgiana Badea

BA
Rotterdam, The Netherlands

Operations

Rongzhe Liu

Bethesda, United States

Jenna Bhaloo

Bethesda, United States

Strategic Market Access

Alison Ford

York, United Kingdom

Operations

Michael Mersky

BA
Bethesda, United States

Operations

“It is very satisfying to work at a place that truly values and invests in the professional growth of its staff.”

Tim Inocencio, Associate Director

“The fun part is working on a diverse array of projects and understanding how different bits fit together to form a complete picture.”

Varun Ektare, Scientist

“Working at Pharmerit is generating the best evidence, taking into account clients’ needs and applying the best research practices.”

Walter Bouwmeester, Senior Research Scientist
Modeling & Meta-Analysis

Modeling & Meta-Analysis

Developing tools to inform policy decision-makers about the clinical and health-economic consequences of health technologies

Patient-Centered Outcomes

Patient-Centered Outcomes

Including the patient perspective to better understand their needs, design better studies, and assess how they value different therapies

Real-World Evidence

Real-World
Evidence

Informing decision-making with evidence from “real-world” practice

Strategic Market Access

Strategic Market Access

Communicating the evidence regarding unmet needs and the benefits and costs of treatment innovation to ensure market access and reimbursement